In summary, our MR analysis lends credence to a causal connection between Lp(a)levels and the risk of CVDs including CAD, AF, HF, hypertension, and PAD,suggesting individuals may benefit from reducing Lp(a) levels, which can beexpected to be a new target for lowering cardiovascular risk. The gene discussed is LPA; the disease is Hypertension.